Clinical Trial Update: Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) [Phase 3]

View source ↗

Summary

Phase 3 trial update for cannabidiol (GWP42003-P) in infantile spasms has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Spasms

Drugs mentioned

• cannabidiol (GWP42003-P) (cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Infantile Spasms | Phase 3 | Status: COMPLETED | Results posted: 2020-07-23